the speculator

Part of the Article;


I expect the shares will advance further in coming weeks as the company’s excluded foreign shareholders (it is traded on America’s over-the-counter market) seek to participate in the potential of the current trials being launched at prestigious American teaching hospitals. They include the Mt Sinai Comprehensive Cancer Research Centre in Miami, Florida; the Huntsman Cancer Institute at the University of Utah; and more recently, the Mary Crowley Cancer Centre in Dallas, Texas. It’s worth mentioning that all three approached the company and not the other way around.

On November 21, Viralytics announced the appointment of a new non-executive director – leading American virologist Dr Leonard Post and a former director of rival Biovex Ltd, a company taken over by Amgen Inc for more than $US 1 billion earlier this year.